Baird Financial Group
HQL icon

Baird Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History

Baird Financial Group’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13,287
Closed -$375K – 1281
2015
Q2 		$375K Buy
+13,287
New +$368K ﹤0.01% 1063

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Needham Investment Management
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Advisors Asset Management
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Ladenburg Thalmann Financial Services
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Doliver Advisors
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return

Baird Financial Group's HQL Position: Q3 2015 in Review

Baird Financial Group sold out of abrdn Life Sciences Investors (HQL) in Q3 2015, closing a stake of 13,287 shares — an estimated $375K sold.

Baird Financial Group first reported a position in HQL in Q2 2015 and held it in 1 quarter. The position peaked at $375K in Q2 2015. 48 funds tracked by Wall St. Rank hold HQL as of Q3 2015.

  • Baird Financial Group reported no remaining abrdn Life Sciences Investors position as of Q3 2015 after selling out during the quarter.
  • Baird Financial Group sold 13,287 abrdn Life Sciences Investors shares in Q3 2015, an estimated $375K.
  • Baird Financial Group first reported a position in abrdn Life Sciences Investors in Q2 2015 and held it in 1 quarter.
  • Baird Financial Group's abrdn Life Sciences Investors position peaked at $375K in Q2 2015.
  • 48 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2015.

Based on Baird Financial Group's 13F filing for Q3 2015, filed 12 Nov 2015.